Canopy Growth (TSX: WEED) (NYSE: CGC) has issued updates on important developments in the United Kingdom and Luxembourg. The company’s pharmaceutical business Spectrum Therapeutics is engaged in expanding its pan-European cannabis production and distribution network in the UK and Luxembourg to serve the needs of physicians and their patients. Canopy aims to transform healthcare in […]The post Canopy Is Flourishing in U.K. and Luxembourg appeared first on Market Exclusive. …read more
Source:: Yahoo Finance
